Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy

Abstract The emergence of multi-omics technologies has enabled the integration of genomic, transcriptomic, epigenomic, proteomic, and metabolomic data to characterize the molecular complexity of cancer. Single-cell and spatial profiling further resolve intratumoral heterogeneity, cell–cell interactions, and the microenvironmental determinants of therapeutic responses. In parallel, artificial intelligence (AI) provides computational approaches for integrating these heterogeneous data types across target identification, drug response prediction, toxicity assessment, and drug-combination modeling. Across these domains, the available evidence indicates that multi-omics integration is most beneficial when the included layers provide complementary biological information; that single-cell and spatial omics analyses reveal treatment-resistant populations and niches but remain largely research-grade and thus not ready for routine clinical deployment; and that although foundation models support some representation-learning tasks, their advantages in perturbation-response prediction require confirmation via stringent evaluation. By distinguishing externally validated advances from retrospective proof-of-concept studies, we provide a practical framework for evaluating the translational readiness of AI-driven multi-omics tools in precision oncology.

Authors

Institutions

Publication Details

Journal
Acta Pharmacologica Sinica
Published
2026-11-16
DOI
https://doi.org/10.1038/s41401-026-01958-8
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy

Xinying Zhang, Junwen Wang, Yaohua Hu, Yongqiang Zhou et al.
Acta Pharmacologica Sinica
Computational Drug Discovery Methods
article

Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy

Xinying Zhang, Junwen Wang, Yaohua Hu, Yongqiang Zhou, Jing Qin, Zhuo-bin Chen, Yi-le Yang, Qi-yue Wang, Yong Liu
article en

Abstract

Abstract The emergence of multi-omics technologies has enabled the integration of genomic, transcriptomic, epigenomic, proteomic, and metabolomic data to characterize the molecular complexity of cancer. Single-cell and spatial profiling further resolve intratumoral heterogeneity, cell–cell interactions, and the microenvironmental determinants of therapeutic responses. In parallel, artificial intelligence (AI) provides computational approaches for integrating these heterogeneous data types across target identification, drug response prediction, toxicity assessment, and drug-combination modeling. Across these domains, the available evidence indicates that multi-omics integration is most beneficial when the included layers provide complementary biological information; that single-cell and spatial omics analyses reveal treatment-resistant populations and niches but remain largely research-grade and thus not ready for routine clinical deployment; and that although foundation models support some representation-learning tasks, their advantages in perturbation-response prediction require confirmation via stringent evaluation. By distinguishing externally validated advances from retrospective proof-of-concept studies, we provide a practical framework for evaluating the translational readiness of AI-driven multi-omics tools in precision oncology.

Acta Pharmacologica Sinica
Sun Yat-sen University (CN), Guangxi Minzu University (CN), Shenzhen University (CN), Zhejiang University (CN), University of Hong Kong (HK)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon